Cargando…

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA

BACKGROUND: Preclinical studies have shown that the novel isoxazoline, lotilaner (Credelio™, Elanco) administered orally to dogs, produces rapid flea and tick knockdown and sustained speed of kill for at least a month post-treatment with a wide safety margin. A field study was undertaken to validate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karadzovska, Daniela, Chappell, Kimberly, Coble, Shane, Murphy, Martin, Cavalleri, Daniela, Wiseman, Scott, Drake, Jason, Nanchen, Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664423/ https://www.ncbi.nlm.nih.gov/pubmed/29089063 http://dx.doi.org/10.1186/s13071-017-2469-x

Ejemplares similares

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA
por: Chappell, Kimberly, et al.
Publicado: (2021)

A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Efficacy of lotilaner (Credelio™) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs
por: Young, Lisa, et al.
Publicado: (2020)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America
por: Murphy, Martin, et al.
Publicado: (2017)

Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™)
por: Kuntz, Emmanuelle A., et al.
Publicado: (2017)

Safety of lotilaner flavoured chewable tablets (Credelio(TM)) after oral administration in cats
por: Kuntz, Emmanuelle A., et al.
Publicado: (2018)

Efficacy of lotilaner (Credelio™) against experimentally induced infestations of the adult cat flea, Ctenocephalides felis, and flea eggs following oral administration to cats
por: Paarlberg, Tandy, et al.
Publicado: (2021)

Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs
por: Murphy, Martin, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Haemaphysalis longicornis infestations of dogs
por: Otaki, Hiroshi, et al.
Publicado: (2018)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio(TM)) against Ixodes ricinus ticks on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio™) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio™) against three common species of ticks affecting dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus
por: Baker, Kim, et al.
Publicado: (2018)

Effectiveness of Credelio(®) Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs
por: Young, Lisa M., et al.
Publicado: (2021)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Amblyomma cajennense (sensu lato) infestations of dogs
por: Lasmar, Pedro Veloso Facury, et al.
Publicado: (2018)

In-home assessment of flea control and dermatologic lesions in dogs provided by lotilaner (Credelio(®)) and spinosad (Comfortis(®)) in west central Florida
por: Dryden, Michael W., et al.
Publicado: (2019)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
por: Young, Lisa M., et al.
Publicado: (2021)

Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA
por: Kryda, Kristina, et al.
Publicado: (2020)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017)

Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
por: Snyder, Daniel E., et al.
Publicado: (2017)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe
por: Forster, Sophie, et al.
Publicado: (2021)

Early onset of pre-lethal effects of lotilaner (Credelio(®)) on Amblyomma americanum ticks on experimentally infested dogs
por: Wenger, Martha J., et al.
Publicado: (2021)

Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) in juvenile and adult dogs
por: Riggs, Kari L., et al.
Publicado: (2021)

Lotilaner - a novel systemic tick and flea control product for dogs
por: Little, Susan E.
Publicado: (2017)

Lotilaner - a novel formulation for cats provides systemic tick and flea control
por: Wright, Ian
Publicado: (2018)

Randomized Placebo‐Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client‐Owned Cats
por: Huhtinen, M., et al.
Publicado: (2015)

Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs
por: Snyder, Daniel E., et al.
Publicado: (2021)

The novel isoxazoline ectoparasiticide lotilaner (Credelio™): a non-competitive antagonist specific to invertebrates γ-aminobutyric acid-gated chloride channels (GABACls)
por: Rufener, Lucien, et al.
Publicado: (2017)

Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA
por: Dryden, Michael W., et al.
Publicado: (2015)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) against natural intestinal nematode infections in dogs presented as veterinary patients in Europe
por: Hayes, Brad, et al.
Publicado: (2021)

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Formulation development of chewable albendazole tablets with improved dissolution rate
por: Kimaro, Emmanuel, et al.
Publicado: (2019)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4atropvm8gdoujhi15jpbu0hk0